Acute hypersensitivity reactions to chlorhexidine in the operating room are probably more likely to occur during the early phases of anaesthesia because chlorhexidine is often used for cleaning the surgical field or during placement of indwelling catheters. We report a case of an acute hypersensitivity reaction that occurred in the post anaesthetic care unit. Subsequent skin testing suggested sensitivity to chlorhexidine, which had been applied over the vaginal mucosa at the end of surgery. Relevant issues in the investigation of acute hypersensitivity reactions in the post anaesthetic period are discussed.
Allergy to chlorhexidine is usually limited to cutaneous reactions and is mild in severity. Allergic or acute hypersensitivity reactions to chlorhexidine usually occur during the early phases of anaesthesia because chlorhexidine is often used for cleaning the surgical field or during placement of indwelling catheters. We describe a case of life-threatening acute hypersensitivity reaction to chlorhexidine which occurred in the post anaesthetic care unit.
CASE HISTORY
A 77-year-old female presented for posterior vaginal repair surgery. She was treated for hypertension with perindopril and metoprolol. At the preadmission clinic, she was noted to be in slow atrial fibrillation but was asymptomatic and had good exercise tolerance. She had no known allergies and had received an uneventful anaesthetic for hysterectomy 14 years previously.
Anaesthesia was induced with intravenous midazolam 1 mg, propofol 70 mg and fentanyl 25 µg. A laryngeal mask airway was inserted and anaesthesia was maintained with isoflurane in oxygen-enriched air. The surgical field was cleaned with a povidoneiodine solution. She received cephalothin 1 g, morphine 3 mg and 1 litre of Hartmann's solution intraoperatively. The patient was stable throughout the procedure which took 1.5 hours. Paracetamol and diclofenac suppositories were administered per rectum upon completion of the procedure. The laryngeal mask was removed when she was awake and the patient was transported to the post anaesthetic care unit (PACU).
On arrival at the PACU three minutes later, the patient was noted to be cyanosed (oxygen saturation of 85%) in spite of receiving oxygen via a Hudson mask. Her ventilation was assisted immediately using 100% oxygen via a facemask. There was no difficulty in lung ventilation and her breath sounds were normal on auscultation.
Her blood pressure was initially 70/32 mmHg, but became unrecordable for two to three minutes. Her peripheral pulses were not palpable and pulse oximetry was not recordable. The patient's blood pressure did not improve with two boluses of intravenous metaraminol 0.5 mg and 500 ml of Hartmann's solution. Treatment for presumed anaphylaxis was commenced. At this point the patient was noted to have generalized erythema. Her blood pressure normalized transiently after a slow intravenous dose of 50 µg adrenaline. A further 50 µg adrenaline administered intravenously three minutes later was associated with rapid atrial fibrillation. There was no stridor or bronchospasm and adequate spontaneous ventilation returned. To facilitate blood pressure monitoring, an arterial catheter was inserted, and an adrenaline infusion (0.03-0.05 µg/kg/min) was titrated to maintain a mean arterial blood pressure of 60 to 65 mmHg without causing rapid atrial fibrillation. The patient received 1litre of succinylated gelatin solution (Gelofusine ®, B Braun [Australia], Bella Vista, New South Wales, Australia), intravenous hydrocortisone 100 mg and promethazine 25 mg in PACU. Blood samples were obtained for troponin T and mast cell tryptase assays one hour after arrival in PACU. The adrenaline infusion was ceased after 15 minutes when her blood pressure was stable. She was transferred to a high dependency unit for further observation and monitoring. She received further paracetamol and diclofenac for postoperative analgesia and made an uneventful recovery. Laboratory investigations showed that the mast cell tryptase concentration was elevated at 46.5 µg/l (normal <11.4 µg/l), supporting the diagnosis of acute hypersensitive reaction 1 . Troponin I concentration was less than 0.1 µg/l (normal <0.1 µg/l).
The patient underwent intradermal skin testing five weeks after surgery according to the Fisher protocol 2 . She was tested for reactions to intravenous induction agents (propofol, thiopentone, midazolam), neuromuscular blocking agents (vecuronium, cisatracurium, pancuronium), opioids (morphine, pethidine, fentanyl), and antibiotics (cephalothin, cefotaxime, penicillin, vancomycin). The patient and primary investigator were blinded to the identities of the agents. There were no reactions to intradermal injections of normal saline, the intravenous induction agents, neuromuscular blocking agents, opioids, or antibiotics. Allergy to paracetamol and diclofenac was considered to unlikely because the patient received these drugs for postoperative analgesia without any sequelae.
Upon review of the case, it was noted that the gynaecologist had applied Obstetric Care™ (Orion Laboratories, Welshpool, Western Australia, Australia), an antibacterial lubricant containing chlorhexidine gluconate 1%, to the perineum at the end of the procedure. This emollient lotion was applied to facilitate post-repair vaginal examination, and to act as a mild antiseptic over the surgical wound. The patient was therefore tested for allergy to chlorhexidine at the same time.
A prompt and marked wheal measuring 15 mm in diameter on top of the flare measuring greater than 30 mm appeared in response to intradermal injections of 0.005% and 0.0005% chlorhexidine (prepared by 1:100 and 1:1000 dilutions of 0.5% chlor-hexidine in 70% alcohol). The patient complained of severe pruritus, which was transient. These reactions suggested a positive test to chlorhexidine. No skin reactions to alcohol or to Obstetric Care™ were observed when these were applied to intact skin. Intradermal tests were negative for all other agents tested. A control subject did not manifest a reaction to either dilution of chlorhexidine. The patient was advised to avoid future use of chlorhexidine, especially on non-intact skin.
DISCUSSION
Chlorhexidine (1:6-di[chlorophenyldiguanido] hexane) is a bisbiguanide and is widely used as an antiseptic in medical practice as well as in items used for routine hygiene such as mouthwash and toothpaste. Its widespread use therefore raises its potential for sensitization in the general population as well as in health care workers. Chlorhexidine is formulated with gluconic or acetic acid to form digluconate or diacetate salts as it is insoluble in water. It binds strongly to skin and mucosal surfaces and this is mediated by its N-chlorinated derivative which binds covalently to protein. There is negligible systemic absorption if the mucous membranes are intact.
Contact dermatitis is a common adverse effect of chlorhexidine, although it can also cause gingivitis, teeth discolouration and distorted taste. Conjunctival contact with chlorhexidine can cause permanent damage and contact with the tympanic membrane can cause ototoxicity. Chlorhexidine can also cause contact urticaria, photosensitivity, fixed drug eruptions and occupational asthma. Although contact sensitivity to chlorhexidine appears to be uncommon, larger studies have estimated a sensitization rate of about 2% in the general population 3 .
Hypersensitivity reactions have been reported with the use of chlorhexidine as a skin disinfectant for surgery [4] [5] [6] , urological procedures 7-11 , insertion of epidural catheters 12 and as an antiseptic for mucous membranes [13] [14] [15] . Reactions have also been reported with the use of chlorhexidine-coated central venous catheters 16, 17 and over-the-counter antiseptics 18, 19 and lubricant gel 20 . Acute hypersensitivity reactions to chlorhexidine can be either anaphylactic or anaphylactoid in nature, although they are indistinguishable clinically.
The clinical manifestations of anaphylaxis are due to the acute release of mediators from mast cells and possibly basophils 20 . Susceptible individuals exposed to the antigen produce IgE which bind to mast cells and basophils. On subsequent exposure, the antigen cross-links two IgE receptors, causing release of mediators such as histamine, tryptases, proteoglycans and platelet-activating factors and generation of inflammatory leukotrienes and prostaglandins. Anaphylactoid reactions are initiated by activation of the complement system and direct activation of mast cells. Clearly distinguishing between anaphylactic and anaphylactoid reactions is difficult, which is why we have used the term "acute hypersensitivity" reactions.
The symmetrical chlorhexidine molecule consists of two chlorguanide molecules joined by a hexamethylene group. Ohtoshi et al 21 reported that chlorguanide was the antigenic determinant of chlorhexidine. More recent work done by Pham et al demonstrated that the allergenic determinant in a patient who developed three anaphylactic reactions to chlorhexidine comprised the entire molecule 22, 23 . Mediators released from both anaphylaxis and anaphylactoid reactions result in cutaneous (flushing, pruritus, urticaria, angioedema), gastrointestinal (nausea, vomiting, diarrhoea), respiratory (rhinitis, laryngeal oedema, dyspnoea, bronchospasm, respiratory arrest), and cardiovascular (tachycardia, hypotension, arrhythmias, cardiovascular collapse) symptoms and signs 24 .
Acute hypersensitivity reactions during the perioperative period are likely to be under-reported, but the incidence has been estimated to range from 1 in 3,500 to 1 in 20,000 [25] [26] [27] [28] . Acute hypersensitivity reactions to chlorhexidine are very rare and the exact prevalence is unknown. The United Kingdom Committee on Safety of Medicines received 182 reports of reactions to products containing chlorhexidine from 1965 to 1996 and these included two cases of anaphylactic shock 13 . In Japan, there have been 15 reported cases of anaphylactic shock related to the use of chlorhexidine. In 1984, the Japanese Ministry of Welfare recommended that the use of chlorhexidine on mucous membranes be prohibited 29 . In 1985, the Japanese manufacturer advised against the use of chlorhexidine gluconate on mucous membranes, and recommended that chlorhexidine gluconate be used on wound surfaces at the lowest bactericidal concentration of 0.05%. The Drug Safety Unit of the Dutch Inspectorate for Health Care received 992 reports of anaphylaxis between 1974 and 1994. Chlorhexidine was implicated in seven of these cases, where five were deemed to be "anaphylaxis probable" and the rest were thought to be "anaphylaxis possible" 30 . The Danish Anaesthesia Allergy Centre established in 1998 has completed investigations in 36 subjects who suffered anaphylactoid reactions referred to it up till July 2001. Four patients tested positive to chlorhexidine out of the 21 patients who had positive tests to various agents 31 . The occurrence of hypersensitivity reactions to chlorhexidine had prompted questions about the risk of sensitization and allergy to this substance among health care workers. One hundred and four health care workers from Denmark underwent patch tests and prick tests to determine the incidence of type IV and type I hypersensitivity reactions to chlorhexidine respectively 32 . None of these health care wqorkers tested positive. However 23 of 307 Japanese doctors who responded to a self-administered questionnaire reported contact dermatitis secondary to chlorhexidine 33 .
The diagnosis of an acute hypersensitivity reaction to chlorhexidine in this patient is supported by the classical features of cardiovascular and dermal involvement, which was associated with the marked increase in mast cell tryptase concentration 1 , and the positive intradermal skin tests. However Garvey et al described false positive reactions to chlorhexidine in aqueous solutions greater than 0.0002% 31 . The validity of the positive intradermal test in our patient is therefore debatable because we used a 0.0005% alcohol based solution of chlorhexidine.
There are several interesting features in this case. The acute hypersensitivity reaction occurred on arrival in the PACU, within 20 to 40 minutes after exposure to chlorhexidine, diclofenac and paracetamol, and this corresponded to the time reported by Garvey et al 12 . There was no bronchospasm during the anaphylactic episode in this patient. A recent review of clinical markers of anaphylactic and anaphylactoid reactions reported that bronchospasm was a feature in 43% with allergy proven anaphylaxis and 28% in acute hypersensitivity reactions 34 . The positive intradermal test to chlorhexidine suggests that systemic absorption occurred when the chlorhexidine cream was applied to the surgical wound in her vaginal mucosa, resulting in the acute hypersensitivity reaction. An intact epidermis is a barrier to systemic absorption of chlorhexidine.
This case highlights the need for documenting and tracking of all agents/drugs that the patient may be exposed to before, during and after surgery so that the appropriate intradermal tests for allergy can be performed. It also reminds anaesthetists of the allergenicity of chlorhexidine, the novel routes by which it may be administered and the problems it may cause.
